Beam stock forecast.

Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $102.85M. -16.4%. Market Cap / Employee. The market cap of a ...Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Beam Global has risen higher in 7 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%. Is Beam Global Stock Undervalued? The current Beam Global [ BEEM] share price is $6.02. The Score for BEEM is 49, which is 2% below its historic median score of 50, and infers higher risk than normal. Get Beam Therapeutics Inc (BEAM.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Aug 13, 2023 · The Vanguard Group, Inc. is the second largest shareholder owning 8.3% of common stock, and Arch Venture Partners, L.P. holds about 7.1% of the company stock. Furthermore, CEO John Evans is the ...

Find the latest Steel Dynamics, Inc. (STLD) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...A.1 https://beststocks.com/target/aaon-stock-forecasthttps://beststocks.com/target/abt-stock-forecasthttps://beststocks.com/target/abbv-stock-forecasthttps ...

(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...

Lockheed Martin (NYSE:LMT) pays an annual dividend of $12.00 per share and currently has a dividend yield of 2.69%. The company has been increasing its dividend for 21 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 43.84%.Average 51.83 75.87% Upside Low 19.00 -35.53% Downside High 95.00 222.36% Upside Broker Rating Beam Therapeutics Inc. currently has an average brokerage recommendation (ABR) of 1.86 on a scale of... Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...Beam Therapeutics is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. ... We provide commentary based on historical data and analyst forecasts ...NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.

Find the latest Roku, Inc. (ROKU) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...

In 2021, Vertex acquired the rights to 60% of the profits from sales of Crispr Therapeutics gene-editing therapy CTX001, now called exa-cel, for up to $1.1 billion, pending regulatory approval ...

Beam Therapeutics Stock Forecast Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 0.2% based on the past 3 years of stock performance. Beam Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%Most industries use structural steel beams to build their structures due to their strength, ease of construction and durability. The cost of structural steel beams varies depending on their size and shape.This morning Beam, an insurtech startup that provides dental coverage to corporate employees, announced that it has closed an $80 million Series E. Mercato-affiliated Traverse led the investment, with Nationwide insurance joining the deal. ...Stock Price Forecast The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ...Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ... Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.Find real-time MELI - MercadoLibre Inc stock quotes, company profile, news and forecasts from CNN Business.

A high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Infibeam Avenues share price was Rs 20.15 as on 01 Dec, 2023, 03:59 PM IST. Infibeam Avenues share price was up by 0.74% based on previous share price of Rs 20.4. Infibeam Avenues share price trend: Last 1 Month: Infibeam Avenues share price moved up by 6.33%.Nov 29, 2023 · According to 3 stock analysts, the average 12-month stock price forecast for Beam Global stock is $26.67, which predicts an increase of 343.02%. The lowest target is $25 and the highest is $30. On average, analysts rate Beam Global stock as a strong buy. Beam Therapeutics, a leading biotechnology company specializing in the development of precision genetic medicines through base editing, has recently announced Beam Therapeutics Announces Strategic Restructuring and Portfolio Prioritization for Value Creation and LongTerm Growth - Best StocksBased on 5 Buys and 4 Holds, the analyst consensus rates the stock a Moderate Buy. Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast) CareDx, Inc (CDNA) The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition.Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Taiwan Semiconductor Manufacturing Co Ltd have a median target of 115.00, with a high estimate of 130.00 and a low ...

NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.

The Beam Therapeutics stock forecast is 57.069107374265 USD for 2024 November 25, Monday; and 177.367 USD for 2028 November 25, Saturday with technical analysis. Beam Therapeutics (BEAM) stock price prediction is 57.069107374265 USD.Stock Price Forecast. The 20 analysts offering 12-month price forecasts for Nintendo Co Ltd have a median target of 46.72, with a high estimate of 59.00 and a low estimate of 31.78. The median ...Beam Therapeutics (BEAM-1.72%), COMPASS Pathways (CMPS-6.05%), and 908 Devices (MASS-2.56%) are three ARK Invest holdings with strong buy ratings and exceptionally high price targets from the ...7 brokers have issued 12-month price objectives for Sangamo Therapeutics' shares. Their SGMO share price targets range from $1.00 to $10.00. On average, they expect the company's stock price to reach $4.68 in the next twelve months. This suggests a possible upside of 1,150.3% from the stock's current price. View analysts price targets …Stock Price Forecast The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ... According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest …Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsDrug-developer Vaxart ( VXRT -1.13%) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of ...Mar 5, 2023 · Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ... Nov 22, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00.

AUPH Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $14.20 with a high forecast of $15.00 and a low forecast of $13.00. The average price target represents a 71.29% change from the last price of $8.29.

Stock Price Forecast The 12 analysts offering 12-month price forecasts for Beam Therapeutics Inc have a median target of 46.50, with a high estimate of 95.00 and a low estimate of 19.00.

Analyst Forecast. According to 9 analysts, the average rating for BEAM stock is "Buy." The 12-month stock price forecast is $55.22, which is an increase of …Electronic Technology. Industry. Aerospace & Defense. No executives to display. Corporate headquarters. --, --. Find real-time ACHR - Archer Aviation Inc stock quotes, company profile, news and ...Nov 22, 2023 · Beam Global Stock Forecast and Price Target. In recent months, notable analysts have provided yearlong price targets for Beam Global, with the average target coming in at $18.00. If it were to be achieved, this would result in a potential upside of approximately 222 percent from the most recent closing price in November, 2023. Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBeam Therapeutics (BEAM-1.72%), COMPASS Pathways (CMPS-6.05%), and 908 Devices (MASS-2.56%) are three ARK Invest holdings with strong buy ratings and exceptionally high price targets from the ...Beam has raised a $9.5 million Series A round. The company is working on a new web browser that completely rethinks the way you start a web session and browse the web. The startup is founded by Dom Leca and Sébastien Métrot. Dom Leca previo...There are four main types of forecasting methods that financial analysts use to predict future revenues, expenses, and capital costs for a business. While there are a wide range of frequently used quantitative budget forecasting tools, in this article we focus on four main methods: (1) straight-line, (2) moving average, (3) simple linear ...TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com(See BEAM stock forecast on TipRanks) To find good ideas for EV stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy , a newly launched tool that unites all of TipRanks ...

Beam Therapeutics Inc Stock Price History. Beam Therapeutics Inc’s price is currently down 1.73% so far this month. During the month of April, Beam Therapeutics Inc’s stock price has reached a high of $32.82 and a low of $28.62. Over the last year, Beam Therapeutics Inc has hit prices as high as $73.27 and as low as $27.77. Year to date ...Nov 22, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00. Vroom, Inc. (NASDAQ:VRM) posted its earnings results on Tuesday, November, 7th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by $0.18. The company earned $235.63 million during the quarter, compared to analyst estimates of $223.90 million.Instagram:https://instagram. game engine market sharenyse cci newsnasdaq pubmotcmkts amrlf The Beam Global stock forecast is 20.479620872586 USD for 2024 November 26, Tuesday; and 123.436 USD for 2028 November 26, Sunday with technical analysis. Beam Global (BEEM) stock price prediction is 20.479620872586 USD.Real Money Technical Analyst Bruce Kamich gives his updated 2023 market forecast Employees of theStreet are prohibited from trading individual securities. Here's how traders can play this biotech stock. The charts of the building materials ... employer match calculatorwhat it means to short a stock People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing. stock price cart January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 2.00, with a high estimate of 8.00 and a low estimate of 0.50. The ...